ApoB-containing lipoproteins have been demonstrated to be directly associated with the risk of coronary heart disease [7], as indicated by the reduction in cardiovascular risk associated with statin therapy, proportional with the reduction in ApoB [8]. The gene discussed is APOB; the disease is coronary artery disorder.